Policy
Key Activities
Testimony, Hill, and White House Communications
Media Advocacy
Federal Agencies
International Agencies
Key Activities
Deadly Duo: The Synergy Between HIV/AIDS and TB - A Congressional Briefing
This issue brief, released by the Center on June 25th, details the scope on HIV/TB co-infection and calls for an aggressive U.S. response.
Read highlights of the event»
Watch Part one of the event»
Watch Part two of the event»
New Report Highlights Transformative Success of Global AIDS Response in Changing Trajectory of Epidemic, Improving Health Outcomes Beyond AIDS (PDF)
An issue brief released by the Center for Global Health Policy and amfAR, The Foundation for AIDS Research, highlights the transformative success of the global AIDS response in changing the trajectory of the epidemic and improving health outcomes beyond AIDS.
Testimony, Hill, and White House Communications
Dr. Peter Mugyenyi’s testimony before the House Foreign Affairs Subcommittee on Africa and Global Health
Ugandan physician Dr. Peter Mugyenyi told lawmakers about turning away HIV-infected patients in need of treatment, as U.S. funding for PEPFAR has essentially flat-lined.
Christine Lubinski’s Testimony to the Tom Lantos Human Rights Commission on the Ugandan Anti-Homosexuality Bill (PDF) 01/21/2010
The Global Center’s Christine Lubinski tells U.S. lawmakers that Uganda’s proposed Anti-Homosexuality Bill is a violation of human rights and a threat to gains made in combating HIV/AIDS.
HIV Clinicians, Researchers Support Lifting the HIV Immigration Ban
HIVMA applauds the Centers for Disease Control and Prevention (CDC) for its proposal to remove HIV infection from the list of communicable diseases of public health significance.
The Center for Global Health Policy Outlines Concerns about House Proposal for Foreign Aid Reform
Global Center staff, in collaboration with nearly two dozen other groups, submitted a formal response to the House Foreign Affairs Committee expressing deep concerns about how global health would fare under the committee’s initial outline for foreign aid reform legislation. The panel’s outline can be found here .
Letter to Speaker of the House Nancy Pelosi
The Center partnered with Physicians for Humans Rights in developing a sign-on letter to Speaker Pelosi about the disappointing FY10 global health budget. The letter had 24 physician signatures.
House Public Witness Hearing Testimony
Center for Global Health Policy testimony fiscal year 2010 funding for NIH, CDC Global AIDS Program, and CDC Division of TB Elimination
Senate Public Witness Hearing Testimony
Center for Global Health Policy testimony on fiscal year 2010 funding for USAID, Office of the Global AIDS Coordinator and the Global fund
Memo to Ambassador Eric Goosby: Recommendation for US Target Treatment (PDF)
Center for Global Health Policy joins other advocates in calling for bold HIV treatment goals for PEPFAR program
Proposed regulation on prostitution could deter effective HIV prevention efforts, physician experts say in letter to HHS (PDF)
Leaders of the Center for Global Health Policy and the HIV Medicine Association expressed serious concern about a proposed rule requiring PEPFAR-funded organizations to declare their opposition to prostitution and sex trafficking, saying the rule could have a detrimental effect on efforts to reach vulnerable population at high risk for HIV infection.
Media Advocacy
Vice President for Global Health Christine Lubinski was on a Media Call about the White House FY2010 Global Health Budget.
Download the .mp3 file, or listen to it here:
HIV/AIDS and TB Experts Disappointed with the FY10 Global Health Budget
The Obama Administration chooses Dr. Eric Goosby as the Coordinator for OGAC. Click Here to see the announcement.
I Saw the Power of Foreign Medical Aid
Op-ed by IDSA member Jodie Dionne-Odom about the importance of fully funding U.S. global health programs.
Federal Agencies
The White House (Executive Branch) & The Office of the Global AIDS Coordinator (OGAC)
United States Agency for International Development (USAID)
Centers for Disease Control and Prevention (CDC) GAP
Centers for Disease Control and Prevention (CDC) Division of TB Elimination (DTBE)
National Institutes of Health (NIH)
The White House (Executive Branch) & The Office of the Global AIDS Coordinator (OGAC)
Through the President's Emergency Plan for AIDS Relief (PEPFAR) and other initiatives, the United States has led the world in responding to the HIV pandemic in developing countries, especially in the countries located in sub-Saharan Africa where the majority of persons with HIV infection live. PEPFAR is implemented and overseen by the Office of the US Global AIDS coordinator, a post within the U.S. Department of State. Currently, Dr. Eric Goosby serves as Global AIDS Coordinator and Ambassador at Large. (Before being confirmed to that post, Dr. Goosby was a member of the Center's Scientific Advisory Committee.)
First launched in 2004 and reauthorized by the U.S Congress in 2008 as the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act, PEPFAR is the largest governmental initiative ever undertaken against a single disease. The program operates through a number of federal agencies in more than 120 countries to assist in HIV/AIDS care, prevention and treatment. PEPFAR has established 15 primary target countries for its HIV funding; more than 40 percent of HIV-infected people in PEPFAR's focus countries are co-infected with TB. In its reauthorization of PEPFAR, Congress called for spending $48 billion over five years on HIV/AIDS, TB, and Malaria. In addition to PEPFAR initiatives, OGAC also directs U.S. engagement with the Global Fund to Fight AIDS, Tuberculosis, and Malaria.
United States Agency for International Development (USAID)
USAID helps direct and implement US global health programs, supporting a broad range of field programs, research, and other initiatives. On global HIV/AIDS, USAID is an implementing partner for PEPFAR, providing technical leadership on HIV/AIDS prevention, care, and treatment. The agency also manages PEPFAR research and field support programs and monitors the impact of HIV/AIDS programs. USAID is also the lead government agency in international TB control programming, working to expand and bolster TB control programs in 40 countries around the world. The agency promotes interventions such as the Directly-Observed Therapy, Short Course (DOTS) strategy and assists in efforts to strengthen lab capacity, increase case detection, and improve infection control, among other things. The agency also supports specific HIV/TB co-infection programs through its support of WHO’s STOP TB strategy on co-infection, and by implementing co-infection related activities funded by PEPFAR.
Centers for Disease Control and Prevention - GAP
CDC's Global AIDS Program (GAP) helps resource-poor countries prevent HIV infection and improve treatment, care, and support for people living with HIV. The CDC GAP program also helps to build health care capacity and infrastructure. To meet these objectives, CDC sends clinicians, epidemiologists and other health professionals to help foreign governments and health institutions with a range of prevention, care and support activities. Through PEPFAR support, the CDC is also providing extensive support to efforts to strengthen laboratory infrastructure, and to increase screening of TB patients for HIV and of HIV infected patients for TB.
Centers for Disease Control and Prevention - Division of TB Elimination (DTBE)
CDC’s Division of TB Elimination takes the lead on eliminating TB in the United States and provides technical support for global TB activities. CDC collaborates with the World Health Organization, USAID, and national TB programs in host countries to provide technical assistance, conduct operational and clinical research, strengthen laboratory and surveillance capacity, provide training and workforce development, and implement infection control measures.
National Institutes of Health (NIH)
NIH is the principle federal agency conducting and supporting US scientific and medical research. The NIH Office for AIDS Research (OAR) overseas the scientific and policy components of the agency’s AIDS program. Within NIH, the National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research on infectious diseases such as AIDS and tuberculosis. Through its Division of Acquired Immunodeficiency Syndrome (DAIDS), NIAID directs the US research agenda on HIV/AIDS, including the search for treatment therapies, prevention strategies, and a vaccine. Similarly, NIAID supports research designed to develop better TB diagnostic tools, a more effective vaccine, and shorter treatment regimens.
Back to Top
International Agencies
The Global Fund to Fight AIDS, Tuberculosis, and Malaria
World Health Organization (WHO)
Stop TB Partnership
United Nations and AIDS (UNAIDS)
The Global Fund to Fight AIDS, Tuberculosis, and Malaria
Established in 2001, the Global Fund is a partnership among governments, the private sector and nongovernmental organizations. Partners contribute to the Fund, which in turn distributes grants to countries and organizations. The Global Fund provides one-quarter of all HIV financing worldwide and two-thirds of all TB funding to developing countries, including significant funding to those countries hardest hit by HIV/TB co-infection. The U.S. has contributed roughly one-third of the resources for the Global Fund’s $15 billion in grants. In addition, USAID, CDC and PEPFAR have played a crucial role in helping developing countries implement Global Fund TB and HIV grants.
World Health Organization (WHO) HIV/AIDS & World Health Organization (WHO) Tuberculosis
The World Health Organization is the United Nations’ coordinating health agency. In addition to its broad leadership role in global health, WHO helps establish international treatment standards, details evidence-based policies, provides technical support to countries, and tracks disease outbreaks and other health trends.
STOP TB Partnership
The Stop TB Partnership is a project of the World Health Organization.
United Nations and AIDS (UNAIDS)
UNAIDS was established in 1994 by the United Nations’ Economic and Social Council as a joint program focused on HIV/AIDS; it is governed by a representatives from 22 governments, officials from nongovernmental organizations, and co-sponsors such as the United Nations Population Fund and the World Health Organization. Headquartered in Geneva, Switzerland, UNAIDS works in more than 80 countries worldwide, coordinating UN efforts and resources on AIDS.
Back to Top